Furthermore, GLP-1RA is related to decreased body weight, which is unfavorable for bone fractures as weight loss induces mechanical loading and bone mass decrease
Who should avoid it, warning signs to watch for, and what to know before combining it with other compounds
1998, 274: R746-R753
Description TIRZEPATIDE INFOR MATION (GLP-1 + GIP) BENEFITS Decreased appetite and cravings Weight loss Clinical trials showed 15% to 30% weight loss depending on doses Each individual loses weight at their own rate Compounded formulas are compounded with medication to help alleviate side effects of nausea Injections are once weekly You can repeat program as many times as you wish COMMON SIDE EFFECTS Nausea Constipation Upset stomach Indigestion RISK OF THYROID C-CELL TUMORS If you or any family member has been diagnosed with Multiple Endocrine Neoplasia Syndrome Type 2 or medullary thyroid cancer you should not take Tirzepatide INFORMATION Tirzepatide is a combination glucagon-like peptide 1 (GLP-1) receptor AND glucose-dependent insulinotropic polypeptide (GIP) receptor agonist that acts on areas of brain that regulate food intake and appetite
Evidence suggests that higher protein intakes (1.01.2g per kilogram body weight) may be beneficial during active weight loss, particularly in older adults, though individual requirements vary
Successfully navigating these common side effects should be viewed not just as a way to improve comfort, but as a core component of the overall strategy for healthy weight loss on GLP-1 medications
&srotate=0)
5452.jpg)
